Skip to main content

Together we are beating cancer

Donate now

Cancer News

The latest news, analysis and opinion from Cancer Research UK

Clinical trials

Showing 12 out of 309 results
  • Science & Technology
  • Health & Medicine

The shape of all things – the year of crystallography

To mark the year of crystallography, we focus on an important scientific duo who used this powerful tool to help develop cancer drugs. To mark the year of crystallography, we focus on an important scientific duo who used this powerful tool to help develop cancer drugs.

by Kathy Weston | Analysis | 23 December 2014

23 December 2014

This entry is part 20 of 30 in the series Our milestones

In the second part of this two-part series, we look at our work with industry, why it's important, and how we try to influence the way drugs get to patients. In the second part of this two-part series, we look at our work with industry, why it's important, and how we try to influence the way drugs get to patients.

by Emma Smith | Analysis | 17 December 2014

17 December 2014

This entry is part 2 of 2 in the series Dances with Pharma
Drugs

In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs. In this first in a two-part series, we take a look at how cancer drugs get to patients, and at some of reasons behind the spiralling costs.

by Emma Smith | Analysis | 16 December 2014

16 December 2014

This entry is part 1 of 2 in the series Dances with Pharma

We take a look at the latest data from a clinical trial testing a 'sponge on a string' as a new way to detect oesophageal cancer early. We take a look at the latest data from a clinical trial testing a 'sponge on a string' as a new way to detect oesophageal cancer early.

by Emily Howlett | Analysis | 2 December 2014

2 December 2014

Chest X-ray

November is lung cancer awareness month, so we've pulled together key information about the disease and what we’re doing to improve survival. November is lung cancer awareness month, so we've pulled together key information about the disease and what we’re doing to improve survival.

by Nick Peel | Analysis | 9 November 2014

9 November 2014

  • Science & Technology
  • Health & Medicine

NCRI 2014 conference summary - day 1

Here's our round up from day one of the NCRI cancer conference in Liverpool Here's our round up from day one of the NCRI cancer conference in Liverpool

by Henry Scowcroft | Analysis | 3 November 2014

3 November 2014

PARP and inhibitor

Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK? Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?

by Kat Arney | Analysis | 24 October 2014

24 October 2014

  • Health & Medicine
  • Science & Technology

Classifying leukaemia: one size doesn’t fit all

A landmark research paper in 1977 changed the way children with acute leukaemia are diagnosed and treated. We look at the story of a research milestone. A landmark research paper in 1977 changed the way children with acute leukaemia are diagnosed and treated. We look at the story of a research milestone.

by Anthea Martin | Analysis | 26 September 2014

26 September 2014

This entry is part 18 of 30 in the series Our milestones
Family on beach

Depression is an important but largely under-recognised problem for people with cancer, but a new treatment programme could improve quality of life for patients Depression is an important but largely under-recognised problem for people with cancer, but a new treatment programme could improve quality of life for patients

by Aine McCarthy | Analysis | 29 August 2014

29 August 2014